FDA Approved: APTENSIO XR — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved a supplemental application for Aptensio XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE)